NL-OMON23812已完成不适用
Endoscopic ultrasound and 11C-5-HTP PET screening for pancreatic neuroendocrine tumors in Multiple Endocrine Neoplasia type 1 and Von Hippel-Lindau disease.
dr. T.P. Links0 个研究点目标入组 90 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •The study populations covers two different groups:
- •1. Group A: MEN1 or VHL patients with signs of a pancreatic tumor (biochemically and/or on conventional imaging) will undergo regular follow-up visits to control tumor localization. These patients are eligible for inclusion providing that the time period between the available conventional imaging data and the investigational imaging procedures does not exceed 4 months;
排除标准
- •1. Patients with any signs of neurological or psychiatric disorders that will preclude him/her from expressing her/his own free will;
- •2. Pregnancy;
研究者
相似试验
已完成
不适用
Towards endoscopic ultrasound and 11C-5-HTP PET screening for pancreatic neuroendocrine tumors in Multiple Endocrine Neoplasia type 1 and Von Hippel Lindau diseasePancreas tumors10052547NL-OMON32173niversitair Medisch Centrum Groningen90
招募中
4 期
PEUSstudypancreatobiliary diseaseJPRN-jRCTs071180072ueki toshiharu600
招募中
不适用
Molecular Evaluation of Pancreatic CancerACTRN12620000762954Dr Daniel Croagh150
尚未招募
不适用
Endoscopic Ultrasound Molecular Evaluation of Pancreatic Cancer Trial 2Pancreatic CancerACTRN12622000904774Monash Health Department of Upper GI Surgery125
已完成
不适用
se of ultrasound to confirm tube is correctly placed inside the wind pipe by trainee anaesthetist before surgery.CTRI/2018/03/012820All India Institute Of Medical Sciences120